Protein-Arginine Deiminase Type 2

A widely expressed isoenzyme of peptidylarginine deiminase, a post-translational modification enzyme that catalyzes the conversion of protein-bound ARGININE residues to CITRULLINE residues in a CALCIUM ion-dependent manner.

Also Known As:

PADI2 Protein; Peptidyl Arginine Deiminase Type 2; Peptidyl Arginine Deiminase Type II; Peptidylarginine Deiminase II; Peptidylarginine Deiminase Type 2; Peptidylarginine Deiminase Type II; Protein Arginine Deiminase 2; Protein Arginine Deiminase Type 2; Protein Arginine Deiminase Type II; Protein-Arginine Deiminase Type II

Networked: 13 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Protein-Arginine Deiminases: 285
      - Protein-Arginine Deiminase Type 2: 13
        human PADI2 protein
        mouse Padi2 protein
        rat Padi2 protein

Experts

1.	E, Qiukai: 1 article (03/2021)
2.	Han, Yun: 1 article (03/2021)
3.	Li, Ying: 1 article (03/2021)
4.	Liu, Shuting: 1 article (03/2021)
5.	Liu, Xiaoqiu: 1 article (03/2021)
6.	Ma, Zhinan: 1 article (03/2021)
7.	Thompson, Paul: 1 article (03/2021)
8.	Xue, Teng: 1 article (03/2021)
9.	Zhang, Mei: 1 article (03/2021)
10.	Zhang, Xuesen: 1 article (03/2021)

Related Diseases

1.	Biliary Tract Neoplasms (Biliary Tract Cancer) 08/16/2023 - "Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer." 08/16/2023 - "This study aimed to evaluate the prognostic value of peptidylarginine deiminase 2 (PADI2) protein expression in biliary tract cancer (BTC) patients. "
2.	Neoplasms (Cancer) 01/01/2020 - "Finally, we established that PADI2 protein is expressed in primary serous endometrial tumors. " 08/16/2023 - "Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer." 04/01/2020 - "Peptidyl arginine deiminase, type II (PADI2) expression has been shown to potentiate multiple different carcinogenesis pathway including breast carcinoma and spontaneous skin neoplasia. " 01/01/2020 - "Peptidylarginine deiminase type II(PADI II) has been shown to enhance a variety of cancers carcinogenesis, including ovarian cancer. " 01/01/2021 - "Immunohistochemical analysis of 422 breast tumor tissues revealed increased expression of PADI2 in ER- tumors (p<0.0001); PADI2 protein expression was positively correlated (p<0.0001) with peptidyl-citrulline staining. "
3.	Rheumatoid Arthritis 11/01/2007 - "Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation." 01/01/2020 - "To address the independent roles of peptidylarginine deiminase type 2 (PAD2) and PAD4 in generating rheumatoid arthritis (RA) autoantigens by using a system that mimics intracellular citrullination in the RA joint. " 03/01/2018 - "The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis." 01/01/2017 - "Protein arginine deiminase 2 (PAD2) plays a key role in the onset and progression of multiple sclerosis, rheumatoid arthritis, and breast cancer. " 01/01/2021 - "The aberrant upregulation of protein arginine deiminase 2- (PAD2-) catalyzed citrullination is reported in various autoimmune diseases (rheumatoid arthritis and multiple sclerosis) and several cancers. "
4.	Breast Neoplasms (Breast Cancer) 04/01/2020 - "Peptidyl arginine deiminase, type II (PADI2) expression has been shown to potentiate multiple different carcinogenesis pathway including breast carcinoma and spontaneous skin neoplasia. " 01/01/2017 - "Protein arginine deiminase 2 (PAD2) plays a key role in the onset and progression of multiple sclerosis, rheumatoid arthritis, and breast cancer. " 01/01/2021 - "Immunohistochemical analysis of 422 breast tumor tissues revealed increased expression of PADI2 in ER- tumors (p<0.0001); PADI2 protein expression was positively correlated (p<0.0001) with peptidyl-citrulline staining. "
5.	Carcinogenesis 04/01/2020 - "Peptidyl arginine deiminase, type II (PADI2) expression has been shown to potentiate multiple different carcinogenesis pathway including breast carcinoma and spontaneous skin neoplasia. " 01/01/2020 - "Peptidylarginine deiminase type II(PADI II) has been shown to enhance a variety of cancers carcinogenesis, including ovarian cancer. "

Related Drugs and Biologics

1.	Protein-Arginine Deiminases
2.	Citrulline
3.	Messenger RNA (mRNA)
4.	Proteins (Proteins, Gene)
5.	Autoantigens
6.	Arginine (L-Arginine)